UTHR
UTHR
NASDAQ · Biotechnology

United Therapeutics Corp

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$564.94
-4.24 (-0.74%)
As of May 9, 1:05 AM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 16 76%
Hold 5 24%
Sell 0 0%
Price Target
Analyst Price Target -84.3% upside
Low Target $65.70
Average Target $88.53
High Target $121.74
Current Price $564.94
Current
$564.94
Target
$88.53
$65.70 $88.53 avg $121.74
Scenario Analysis
Bear Case
$65.70
-88.4%
Low target
Base Case
$88.53
-84.3%
Avg target
Bull Case
$121.74
+-78.5%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$609.35
-7.3% from high
52-Week Low
$272.12
+107.6% from low
50-Day SMA
$485.49
+16.4% vs SMA
200-Day SMA
$394.55
+43.2% vs SMA
RSI (14)
60.3
Neutral
Target vs 52W High
$88.53
-85.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%